359 related articles for article (PubMed ID: 15160261)
1. Escitalopram versus citalopram: the surprising role of the R-enantiomer.
Sánchez C; Bøgesø KP; Ebert B; Reines EH; Braestrup C
Psychopharmacology (Berl); 2004 Jul; 174(2):163-76. PubMed ID: 15160261
[TBL] [Abstract][Full Text] [Related]
2. [Escitalopram and citalopram: the unexpected role of the R-enantiomer].
Jacquot C; David DJ; Gardier AM; Sánchez C
Encephale; 2007; 33(2):179-87. PubMed ID: 17675913
[TBL] [Abstract][Full Text] [Related]
3. Escitalopram--translating molecular properties into clinical benefit: reviewing the evidence in major depression.
Leonard B; Taylor D
J Psychopharmacol; 2010 Aug; 24(8):1143-52. PubMed ID: 20147575
[TBL] [Abstract][Full Text] [Related]
4. Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram.
Kasper S; Sacher J; Klein N; Mossaheb N; Attarbaschi-Steiner T; Lanzenberger R; Spindelegger C; Asenbaum S; Holik A; Dudczak R
Int Clin Psychopharmacol; 2009 May; 24(3):119-25. PubMed ID: 19367152
[TBL] [Abstract][Full Text] [Related]
5. Escitalopram : a review of its use in the management of major depressive and anxiety disorders.
Waugh J; Goa KL
CNS Drugs; 2003; 17(5):343-62. PubMed ID: 12665392
[TBL] [Abstract][Full Text] [Related]
6. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities.
Sánchez C; Bergqvist PB; Brennum LT; Gupta S; Hogg S; Larsen A; Wiborg O
Psychopharmacology (Berl); 2003 Jun; 167(4):353-62. PubMed ID: 12719960
[TBL] [Abstract][Full Text] [Related]
7. [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].
Mnie-Filali O; El Mansari M; Scarna H; Zimmer L; Sánchez C; Haddjeri N
Encephale; 2007 Dec; 33(6):965-72. PubMed ID: 18789789
[TBL] [Abstract][Full Text] [Related]
8. Escitalopram.
Aronson S; Delgado P
Drugs Today (Barc); 2004 Feb; 40(2):121-31. PubMed ID: 15045034
[TBL] [Abstract][Full Text] [Related]
9. [Mechanisms of action of antidepressants: new data from Escitalopram].
Fabre V; Hamon M
Encephale; 2003; 29(3 Pt 1):259-65. PubMed ID: 12876551
[TBL] [Abstract][Full Text] [Related]
10. Escitalopram: a unique mechanism of action.
Bræstrup C; Sanchez C
Int J Psychiatry Clin Pract; 2004; 8 Suppl 1():11-3. PubMed ID: 24930683
[TBL] [Abstract][Full Text] [Related]
11. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
Pelissolo A
Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
[TBL] [Abstract][Full Text] [Related]
13. Managing depressive and anxiety disorders with escitalopram.
Thase ME
Expert Opin Pharmacother; 2006 Mar; 7(4):429-40. PubMed ID: 16503815
[TBL] [Abstract][Full Text] [Related]
14. Escitalopram: better treatment for depression is through the looking glass.
Malin P; Wengel SP; Burke WJ
Expert Rev Neurother; 2004 Sep; 4(5):769-79. PubMed ID: 15853504
[TBL] [Abstract][Full Text] [Related]
15. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].
Azorin JM; Llorca PM; Despiegel N; Verpillat P
Encephale; 2004; 30(2):158-66. PubMed ID: 15107719
[TBL] [Abstract][Full Text] [Related]
16. [Escitalopram--second generation of serotonin transporter inhibitors?].
Rybakowski J; Borkowska AB
Psychiatr Pol; 2004; 38(2):227-39. PubMed ID: 15307289
[TBL] [Abstract][Full Text] [Related]
17. Escitalopram, an antidepressant with an allosteric effect at the serotonin transporter--a review of current understanding of its mechanism of action.
Zhong H; Haddjeri N; Sánchez C
Psychopharmacology (Berl); 2012 Jan; 219(1):1-13. PubMed ID: 21901317
[TBL] [Abstract][Full Text] [Related]
18. [Escitalopram for treatment of major depressive disorder in adults].
Llorca PM; Brousse G; Schwan R
Encephale; 2005; 31(4 Pt 1):490-501. PubMed ID: 16389716
[TBL] [Abstract][Full Text] [Related]
19. The R-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats.
Mørk A; Kreilgaard M; Sánchez C
Neuropharmacology; 2003 Aug; 45(2):167-73. PubMed ID: 12842122
[TBL] [Abstract][Full Text] [Related]
20. Spotlight on escitalopram in the management of major depressive disorder.
Murdoch D; Keam SJ
CNS Drugs; 2006; 20(2):167-70. PubMed ID: 16478291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
